{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:49:30Z","timestamp":1782168570804,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1781-0","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T15:30:54Z","timestamp":1445700654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Abnormalities in the meibomian glands in patients with oral administration of anticancer combination drug-capsule TS-1\u00ae: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Shin","family":"Mizoguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Kokado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Saika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"key":"1781_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","volume":"7","author":"T Shirasaka","year":"1996","unstructured":"Shirasaka T, Yamamoto Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, et al. Development of a novel form of an oral 5-fluorouracil derivate(S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996;7:548\u201357.","journal-title":"Anticancer Drugs"},{"key":"1781_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jjco\/hyn127","volume":"39","author":"T Shirasaka","year":"2009","unstructured":"Shirasaka T. Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. Jpn J Clin Oncol. 2009;39:2\u201315.","journal-title":"Jpn J Clin Oncol"},{"key":"1781_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0163-7258(81)90068-1","volume":"13","author":"PV Danenberg","year":"1981","unstructured":"Danenberg PV, Lockshin A. Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase. Pharmacol Ther. 1981;13:69\u201390.","journal-title":"Pharmacol Ther"},{"key":"1781_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10120-003-0232-9","volume":"6","author":"Y Maehara","year":"2003","unstructured":"Maehara Y. S-1 in gastric cancer: a comprehensive review. Gastric Cancer. 2003;6:2\u20138.","journal-title":"Gastric Cancer"},{"key":"1781_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/01.IOP.0000066648.33513.3D","volume":"19","author":"AS Eiseman","year":"2003","unstructured":"Eiseman AS, Flanagan JC, Brooks AB, Mitchell EP, Pemberton CH. Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthal Plast Reconstr Surg. 2003;19:216\u201324.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1781_CR6","first-page":"2896","volume":"15","author":"T Chikama","year":"2009","unstructured":"Chikama T, Takahashi N, Wakuta M, Nishida T. Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1. Mol Vis. 2009;15:2896\u2013904.","journal-title":"Mol Vis"},{"key":"1781_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajo.2005.01.052","volume":"140","author":"B Esmaeli","year":"2005","unstructured":"Esmaeli B, Golio D, Lubecki L, Ajani J. Canalicular and nasolacrimal duct blockage:an ocular side effect associated with the antineoplastic drug S-1. Am J Ophthalmol. 2005;140:325\u20137.","journal-title":"Am J Ophthalmol"},{"key":"1781_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911\u20135.","journal-title":"Ophthalmology"},{"key":"1781_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/ICO.0b013e31825425ef","volume":"32","author":"R Arita","year":"2013","unstructured":"Arita R, Itoh K, Maeda S, Maeda K, Amano S. A newly developed noninvasive and mobile pen-shaped meibography system. Cornea. 2013;32:242\u20137.","journal-title":"Cornea"},{"key":"1781_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2131\/jts.21.SupplementIII_527","volume":"21","author":"T Hayashi","year":"1996","unstructured":"Hayashi T, Yamaguchi S, Kito S, Tanaka G, Kurokawa K, Hirota T. An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs:I. A 13-week repeated dose toxicity study, II. An ophthalmologic toxicity recovery study. J Toxicol Sci. 1996;21:527\u201344 (in japanese).","journal-title":"J Toxicol Sci"},{"key":"1781_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/bjophthalmol-2012-302404","volume":"97","author":"SY Jang","year":"2013","unstructured":"Jang SY, Lee SY, Yoon JS. Meibomian gland dysfunction in longstanding prosthetic eye wearers. Br J Ophthalmol. 2013;97:398\u2013402.","journal-title":"Br J Ophthalmol"},{"key":"1781_CR12","first-page":"363","volume":"65","author":"K Katsumura","year":"2011","unstructured":"Katsumura K, Ochi R, Koumoto R, Hattori M, Shimizu K, Sato B, et al. Instillation of autologous serum was effective in two cases of corneal disorders secondary to anticancer drug TS-1 \u00ae. Jpn J Clin Ophthalmol. 2011;65:363\u20137 (in japanese).","journal-title":"Jpn J Clin Ophthalmol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1781-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T18:07:57Z","timestamp":1475777277000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1781-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1781"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1781-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]},"article-number":"796"}}